Durban, 20 June 2013 – The medical organization Médecins Sans Frontières/Doctors Without Borders (MSF) today released new evidence at the 6th South African AIDS Conference in Durban on early success using the high-strength antibiotic, linezolid as part of a treatment regimen for patients with extensively drug-resistant tuberculosis (XDR-TB). This is some of the first clinical data from both an African and primary care context suggesting that linezolid is safe and effective for treating patients with XDR-TB, including those co-infected with HIV.

People living with MDR-TB and their healthcare providers call for urgent action.

Médecins Sans Frontières, Drugs for Neglected Diseases initiative, Mount Sinai School of Medicine’s Global Health Program convene medical experts from around the world for New York conference

New MSF multinational study of paediatric TB/HIV co-infection confirms crisis of undiagnosed TB among children.

Médecins Sans Frontières data results reveal urgent need to scale up drug-resistant tuberculosis treatment.

2012 International Union Against TB and Lung Disease World Conference
Date: 16 November 2012
Time: 8h00 - 10h00
Location: Kuala Lumpur Convention Center, rooms 401+402

In her home on the outskirts of Zimbabwe’s capital city, 48-year-old Mary Marizani says that, although she recently became the first Doctors Without Borders/Médecins Sans Frontières (MSF) patient in the country to conquer multidrug-resistant tuberculosis (MDR-TB), she now faces another challenge: “I have my appetite back and now I am eating everything in sight.”

On 10-year anniversary of landmark Thai case, new ‘Patent Opposition Database’ aims to boost access to medicines in countries increasingly hit by high drug prices.

How the U.S.’s intellectual property demands for the Trans-Pacific Partnership Agreement threaten access to medicines.

The study looks at 25 indicators in each country, ranging from coverage of ART and prevention of mother-to-child transmission, to whether nurses instead of doctors can start patients on HIV and TB treatment.